Premium
Application of the H 2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial
Author(s) -
Myhre Peder L.,
Vaduganathan Muthiah,
Claggett Brian L.,
Lam Carolyn S.P.,
Desai Akshay S.,
Anand Inder S.,
Sweitzer Nancy K.,
Fang James C.,
O'Meara Eileen,
Shah Sanjiv J.,
Shah Amil M.,
Lewis Eldrin F.,
Rouleau Jean,
Pitt Bertram,
Solomon Scott D.
Publication year - 2019
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.1542
Subject(s) - medicine , heart failure , ejection fraction , heart failure with preserved ejection fraction , spironolactone , cardiology , population , clinical trial , randomization , randomized controlled trial , placebo , blood pressure , alternative medicine , environmental health , pathology